Trusted Sources

PARAPLATIN Questions ? Need a second opinion? Ask Our Health Experts!

Type your question here

 letters left

PARAPLATIN Safety Reports

Total PARAPLATIN reports: 152. PARAPLATIN FDA safety alerts: No. Reported deaths: 41    Reported hospitalizations: 43. Read More Here.

< Previous  Showing 101-150 of 152 Next >

Health Professional from JAPAN reported PARAPLATIN problem on Mar 06, 2006. Male patient, 47 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease. PARAPLATIN dosage: unknown. During the same period patient was treated with VEPESID, ENDOXAN, CYMERIN. Patient recovered.

PARAPLATIN problem was reported by a Health Professional from JAPAN on Mar 06, 2006. Male patient, 56 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease. PARAPLATIN dosage: unknown. During the same period patient was treated with VEPESID, ENDOXAN, CYMERIN. Patient died.

Health Professional from JAPAN reported PARAPLATIN problem on Mar 06, 2006. Female patient, 37 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease. PARAPLATIN dosage: unknown. During the same period patient was treated with VEPESID, ENDOXAN, CYMERIN. Patient recovered.

PARAPLATIN problem was reported by a Physician from JAPAN on Apr 13, 2006. Female patient, 71 years of age, was diagnosed with ovarian cancer and was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: cardiac arrest. PARAPLATIN dosage: unknown. During the same period patient was treated with DOCETAXEL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported PARAPLATIN problem on Apr 17, 2006. Male patient was diagnosed with testis cancer and was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: abdominal distension, abdominal pain upper, fatigue, intestinal functional disorder, loss of consciousness, nausea. PARAPLATIN dosage: unknown. Patient recovered.

PARAPLATIN problem was reported by a Health Professional from JAPAN on Apr 21, 2006. Female patient, 66 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: neutropenia, pneumonia fungal. PARAPLATIN dosage: unknown. During the same period patient was treated with LASTET, METHYLPREDNISOLONE, CYTARABINE, MAXIPIME, ACETAMINOPHEN, NEUTROGIN. Patient recovered.

Physician from UNITED STATES reported PARAPLATIN problem on Nov 08, 2005. Female patient, 63 years of age, was diagnosed with non-small cell lung cancer and was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression. PARAPLATIN dosage: unknown. During the same period patient was treated with GEMCITABINE. Patient died.

PARAPLATIN problem was reported by a Physician from JAPAN on Apr 06, 2006. Male patient, 77 years of age, was diagnosed with lung adenocarcinoma and was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: hyperkalaemia, liver disorder, metabolic acidosis, renal disorder. PARAPLATIN dosage: unknown. During the same period patient was treated with GEMZAR, MAGMITT, LOXONIN, GASTER D, MORPHINE, SOLDEM, BROCIN CODEINE. Patient died on 04/06/2006.

Health Professional from JAPAN reported PARAPLATIN problem on Oct 26, 2005. Male patient, 51 years of age, was diagnosed with lung adenocarcinoma and was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: acute respiratory failure, interstitial lung disease, pulmonary haemorrhage. PARAPLATIN dosage: unknown. During the same period patient was treated with GEMZAR, NEUPOGEN. Patient died.

PARAPLATIN problem was reported by a Health Professional from FRANCE on Aug 07, 2002. Female patient, 63 years of age, was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, anaemia, pancytopenia, petechiae. PARAPLATIN dosage: unknown. During the same period patient was treated with ENDOXAN, METHOTREXATE, ONCOVIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported PARAPLATIN problem on Apr 27, 2006. Female patient was diagnosed with lung neoplasm malignant and was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: eczema. PARAPLATIN dosage: unknown. During the same period patient was treated with DOCETAXEL. Patient was hospitalized. Patient recovered.

PARAPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on May 03, 2006. Female patient was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: depression, psychotic disorder. PARAPLATIN dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported PARAPLATIN problem on May 08, 2006. Female patient was diagnosed with ovarian cancer and was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, depressed level of consciousness, hypersensitivity. PARAPLATIN dosage: unknown. Patient recovered.

PARAPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 06, 2006. Female patient, 38 years of age, was diagnosed with lung neoplasm malignant and was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: dyspnoea, infection, lung abscess, malignant neoplasm progression, pain. PARAPLATIN dosage: unknown. During the same period patient was treated with TAXOL. Patient was hospitalized. Patient died on 03/22/2006.

Health Professional from JAPAN reported PARAPLATIN problem on Apr 21, 2006. Female patient, 66 years of age, was diagnosed with diffuse large b-cell lymphoma, non-hodgkin's lymphoma and was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: anaemia, febrile neutropenia, pneumonia fungal, thrombocytopenia. PARAPLATIN dosage: unknown. During the same period patient was treated with LASTET, CYTARABINE, METHYLPREDNISOLONE, MAXIPIME, ACETAMINOPHEN, NEUTROGIN, LANSOPRAZOLE, REBAMIPIDE. Patient recovered.

PARAPLATIN problem was reported by a Physician from JAPAN on Apr 13, 2006. Female patient, 71 years of age, was diagnosed with ovarian cancer and was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, cardiac arrest. PARAPLATIN dosage: unknown. During the same period patient was treated with DOCETAXEL. Patient died on 04/27/2006.

Health Professional from JAPAN reported PARAPLATIN problem on Dec 02, 2005. Male patient, 75 years of age, was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: small intestinal perforation, small intestinal stenosis. PARAPLATIN dosage: unknown. During the same period patient was treated with VEPESID. Patient was hospitalized. Patient recovered.

PARAPLATIN problem was reported by a Physician from UNITED STATES on May 30, 2006. Female patient was treated with PARAPLATIN. PARAPLATIN dosage: unknown. Patient died.

Physician from JAPAN reported PARAPLATIN problem on June 06, 2006. Male patient was diagnosed with lung neoplasm malignant and was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: ileus. PARAPLATIN dosage: unknown. During the same period patient was treated with TAXOL. Patient died on 04/01/2006.

PARAPLATIN problem was reported by a Physician from JAPAN on Dec 27, 2005. Male patient, 74 years of age, was diagnosed with lung neoplasm malignant and was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome. PARAPLATIN dosage: unknown. During the same period patient was treated with TAXOL, OXYCONTIN, MAGNESIUM OXIDE, NOVAMIN, LOXOPROFEN, MUCOSTA. Patient died on 12/12/2005.

Consumer or non-health professional from UNITED STATES reported PARAPLATIN problem on Mar 29, 2006. Male patient was treated with PARAPLATIN. PARAPLATIN dosage: unknown. During the same period patient was treated with TAXOL. Patient died.

PARAPLATIN problem was reported by a Pharmacist from UNITED STATES on Apr 10, 2006. Male patient, 15 years of age, was diagnosed with pineal germinoma and was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: central pontine myelinolysis. PARAPLATIN dosage: unknown. During the same period patient was treated with ETOPOSIDE, DEXAMETHASONE, DESMOPRESSIN. Patient was hospitalized and became disabled. Patient recovered.

Pharmacist from UNITED STATES reported PARAPLATIN problem on June 12, 2006. Female patient was treated with PARAPLATIN. PARAPLATIN dosage: unknown. During the same period patient was treated with TAXOL. Patient died.

PARAPLATIN problem was reported by a Physician from JAPAN on June 06, 2006. Male patient, 81 years of age, was diagnosed with lung neoplasm malignant and was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, ileus paralytic, malignant neoplasm progression. PARAPLATIN dosage: unknown. During the same period patient was treated with TAXOL, SULPERAZON. Patient died on 04/16/2006.

Health Professional from JAPAN reported PARAPLATIN problem on Jan 14, 2003. Male patient, 60 years of age, was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: epistaxis, idiopathic thrombocytopenic purpura, pneumonia. PARAPLATIN dosage: unknown. During the same period patient was treated with TAXOTERE. Patient died on 07/04/2002.

PARAPLATIN problem was reported by a Health Professional from JAPAN on Mar 23, 2006. Female patient, 66 years of age, was diagnosed with peritoneal carcinoma and was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: shock. PARAPLATIN dosage: unknown. Patient recovered.

Consumer or non-health professional from JAPAN reported PARAPLATIN problem on June 22, 2006. Male patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: pulmonary alveolar haemorrhage. PARAPLATIN dosage: unknown. During the same period patient was treated with GEMZAR. Patient was hospitalized. Patient recovered.

PARAPLATIN problem was reported by a Physician from JAPAN on June 30, 2006. Female patient, 80 years of age, was diagnosed with ovarian cancer and was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: asthma, dyspnoea, flushing, wheezing. PARAPLATIN dosage: unknown. During the same period patient was treated with TAXOL, FAMOTIDINE, DEXAMETHASONE PHOSPHATE, GRANISETRON. Patient recovered.

Health Professional from JAPAN reported PARAPLATIN problem on Jan 14, 2003. Male patient, 60 years of age, was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: disease progression, epistaxis, idiopathic thrombocytopenic purpura, pneumonia. PARAPLATIN dosage: unknown. During the same period patient was treated with TAXOTERE. Patient died on 07/04/2002.

PARAPLATIN problem was reported by a Physician from JAPAN on July 10, 2006. Female patient, 67 years of age, was diagnosed with ovarian cancer and was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: cognitive disorder. PARAPLATIN dosage: unknown. Patient was hospitalized. Patient recovered.

Health Professional from JAPAN reported PARAPLATIN problem on June 22, 2006. Male patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: pulmonary alveolar haemorrhage. PARAPLATIN dosage: unknown. During the same period patient was treated with GEMZAR. Patient was hospitalized. Patient recovered.

PARAPLATIN problem was reported by a Consumer or non-health professional from ITALY on July 03, 2006. Female patient, 73 years of age, was diagnosed with ovarian cancer, nausea and was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock. PARAPLATIN dosage: unknown. During the same period patient was treated with TAXOL, KYTRIL. Patient died on 06/15/2006.

Physician from JAPAN reported PARAPLATIN problem on Apr 13, 2006. Female patient, 71 years of age, was diagnosed with ovarian cancer and was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, cardiac arrest. PARAPLATIN dosage: unknown. During the same period patient was treated with DOCETAXEL, GRANISETRON, DEXAMETHASONE PHOSPHATE. Patient died on 04/17/2006.

PARAPLATIN problem was reported by a Health Professional from JAPAN on Mar 23, 2006. Female patient, 66 years of age, was diagnosed with peritoneal carcinoma and was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock. PARAPLATIN dosage: unknown. During the same period patient was treated with SEROTONE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported PARAPLATIN problem on Aug 04, 2006. Male patient, 60 years of age, weighting 149.9 lb, was diagnosed with non-small cell lung cancer and was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: agitation, blood pressure increased, confusional state, pain, repetitive speech. PARAPLATIN dosage: unknown. During the same period patient was treated with GEMZAR, MS CONTIN, METHADONE, LEXAPRO, ZOFRAN, COMPAZINE, PROMETHAZINE. Patient was hospitalized. Patient recovered.

PARAPLATIN problem was reported by a Physician from JAPAN on July 10, 2006. Female patient, 67 years of age, was diagnosed with ovarian cancer and was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: cognitive disorder. PARAPLATIN dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported PARAPLATIN problem on Sept 01, 2006. Male patient, 66 years of age, was diagnosed with non-small cell lung cancer and was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: dizziness, electrocardiogram qt prolonged. PARAPLATIN dosage: unknown. During the same period patient was treated with TAXOL, SORAFENIB, DECADRON, RESTAMIN, ZANTAC, KYTRIL, LOXONIN, MUCOSTA. Patient was hospitalized. Patient recovered.

PARAPLATIN problem was reported by a Pharmacist from JAPAN on Sept 06, 2006. Female patient, 58 years of age, was diagnosed with ovarian cancer and was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, chest discomfort, cyanosis, respiratory arrest, vomiting. PARAPLATIN dosage: unknown. During the same period patient was treated with TAXOL, DEXART, KYTRIL, ZANTAC, VOLTAREN, ALOSENN, MAGNESIUM, DORAL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported PARAPLATIN problem on Aug 04, 2006. Male patient, 60 years of age, weighting 149.9 lb, was diagnosed with non-small cell lung cancer and was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: agitation, blood pressure increased, confusional state, pain, repetitive speech, reversible posterior leukoencephalopathy syndrome. PARAPLATIN dosage: unknown. During the same period patient was treated with GEMZAR, MS CONTIN, METHADONE, LEXAPRO, ZOFRAN, COMPAZINE, PROMETHAZINE. Patient was hospitalized. Patient recovered.

PARAPLATIN problem was reported by a Physician from JAPAN on Mar 28, 2006. Female patient, 81 years of age, was diagnosed with lung neoplasm malignant and was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: arterial occlusive disease, renal disorder, splenic infarction. PARAPLATIN dosage: unknown. During the same period patient was treated with LASTET, CARBOMERCK, GASMOTIN, MUCOSTA, MAGNESIUM OXIDE, GASTER D, AMLODIN. Patient was hospitalized. Patient died.

Pharmacist from JAPAN reported PARAPLATIN problem on Sept 06, 2006. Female patient, 58 years of age, was diagnosed with ovarian cancer and was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, chest discomfort, cyanosis, hypersensitivity, respiratory arrest, vomiting. PARAPLATIN dosage: unknown. During the same period patient was treated with TAXOL, DEXART, KYTRIL, ZANTAC, VOLTAREN, ALOSENN, MAGNESIUM, DORAL. Patient recovered.

PARAPLATIN problem was reported by a Health Professional from FRANCE on Sept 14, 2006. Male patient, 85 years of age, was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: pulmonary fibrosis. PARAPLATIN dosage: unknown. During the same period patient was treated with TAXOL, LASILIX, POTASSIUM CHLORIDE, AMIODARONE, PLAVIX. Patient was hospitalized. Patient died on 08/17/2006.

Health Professional from FRANCE reported PARAPLATIN problem on Sept 13, 2006. Male patient, 56 years of age, weighting 191.8 lb, was diagnosed with small cell carcinoma and was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: pulmonary fibrosis. PARAPLATIN dosage: unknown. During the same period patient was treated with VEPESID, SOLUPRED, LOXEN, ZOLOFT, ASPIRIN, LASILIX, TARDYFERON, FOLIC ACID. Patient was hospitalized. Patient recovered.

PARAPLATIN problem was reported by a Physician from JAPAN on Jan 15, 2007. Female patient, 67 years of age, was diagnosed with uterine cancer and was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage, platelet count decreased, renal failure acute. PARAPLATIN dosage: unknown. During the same period patient was treated with TAXOL. Patient died.

Physician from JAPAN reported PARAPLATIN problem on Jan 19, 2007. Female patient, 67 years of age, was diagnosed with uterine cancer and was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage, platelet count decreased, renal failure acute. PARAPLATIN dosage: unknown. During the same period patient was treated with TAXOL. Patient died.

PARAPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 30, 2006. Female patient, 70 years of age, weighting 189.6 lb, was diagnosed with ovarian cancer and was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: stevens-johnson syndrome. PARAPLATIN dosage: unknown. During the same period patient was treated with TAXOL, DEXAMETHASONE, RANITIDINE, BENADRYL, ZOFRAN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported PARAPLATIN problem on Sept 08, 2006. Female patient, 57 years of age, weighting 97.00 lb, was diagnosed with non-small cell lung cancer and was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: pain. PARAPLATIN dosage: unknown. During the same period patient was treated with TAXOL. Patient was hospitalized. Patient died on 08/17/2006.

PARAPLATIN problem was reported by a Physician from JAPAN on Mar 06, 2007. Male patient, 74 years of age, was diagnosed with lung neoplasm malignant and was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: cholecystitis. PARAPLATIN dosage: unknown. During the same period patient was treated with NAVELBINE. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported PARAPLATIN problem on Mar 08, 2007. Male patient, 74 years of age, was diagnosed with lung neoplasm malignant and was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: cholecystitis, leukopenia. PARAPLATIN dosage: unknown. During the same period patient was treated with NAVELBINE, ZANTAC, DECADRON, SEROTONE, BASEN, EUGLUCAN, ADALAT, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.

PARAPLATIN problem was reported by a Physician from JAPAN on Mar 14, 2007. Male patient, 78 years of age, was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: rhabdomyolysis. PARAPLATIN dosage: unknown. During the same period patient was treated with VEPESID, BEZATOL. Patient was hospitalized and became disabled. Patient recovered.

< Previous  Showing 101-150 of 152 Next >